Zhengye Biotechnology Holding Limited (NASDAQ:ZYBT) Short Interest Update

Zhengye Biotechnology Holding Limited (NASDAQ:ZYBT) was the target of a large decline in short interest in the month of April. As of April 15th, there was short interest totaling 51,122 shares, a decline of 65.4% from the March 31st total of 147,787 shares. Based on an average trading volume of 26,639 shares, the short-interest ratio is presently 1.9 days. Currently, 0.1% of the shares of the company are sold short.

Analysts Set New Price Targets

Separately, Weiss Ratings reaffirmed a “sell (d-)” rating on shares of Zhengye Biotechnology in a report on Friday, January 9th. One investment analyst has rated the stock with a Sell rating, Based on data from MarketBeat.com, Zhengye Biotechnology currently has an average rating of “Sell”.

Zhengye Biotechnology Price Performance

Shares of ZYBT stock opened at $0.92 on Monday. The company’s 50-day moving average price is $0.89 and its 200-day moving average price is $1.46. Zhengye Biotechnology has a twelve month low of $0.68 and a twelve month high of $14.30.

Institutional Inflows and Outflows

A number of large investors have recently bought and sold shares of ZYBT. Citadel Advisors LLC acquired a new position in Zhengye Biotechnology in the third quarter valued at about $31,000. Millennium Management LLC acquired a new position in Zhengye Biotechnology in the third quarter valued at about $38,000. WINTON GROUP Ltd acquired a new position in Zhengye Biotechnology in the third quarter valued at about $56,000. XTX Topco Ltd lifted its position in Zhengye Biotechnology by 71.4% in the fourth quarter. XTX Topco Ltd now owns 59,286 shares of the company’s stock valued at $68,000 after buying an additional 24,697 shares during the last quarter. Finally, Geode Capital Management LLC acquired a new position in Zhengye Biotechnology in the second quarter valued at about $174,000.

Zhengye Biotechnology Company Profile

Zhengye Biotechnology Holding Limited is a veterinary vaccine manufacturer which encompasses research, development, manufacturing and sales of veterinary vaccines, with a focus on livestock vaccine principally in China. Zhengye Biotechnology Holding Limited is based in Jilin, China.